US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alumis Inc.

9.91

+0.10501.07%

Volume:3.87M

Turnover:38.49M

Market Cap:1.28B

PE:-2.61

High:10.55

Open:10.55

Low:9.65

Close:9.80

52wk High:31.35

52wk Low:3.76

Shares:129.00M

Float Shares:104.00M

Volume Ratio:0.66

T/O Rate:3.72%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.8005

EPS(LYR):-2.8616

ROE:-93.65%

ROA:-45.34%

PB:2.83

PE(LYR):-3.46

Loading ...

Overview Company News Filings

Alumis Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS

Alumis Inc reports results for the quarter ended December 31 - Earnings Summary

Alumis Q4 Sales $1.929M Miss $2.833M Estimate

Benzinga Earnings

Alumis Inc. publishes corporate presentation on precision-engineered TYK2 inhibitors for immune-mediated diseases

Alumis FY 2025 G&A expenses jumped 161% to USD 91.86 million as net loss narrowed 17% to USD 243.33 million

Press Release: Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements

Alumis sets late-breaking AAD 2026 oral presentation of Phase 3 ONWARD1 and ONWARD2 envudeucitinib psoriasis data

BRIEF-Alumis Announces Late-Breaker Oral Presentation Of Phase 3 Data For Envudeucitinib In Moderate-To-Severe Plaque Psoriasis At 2026 American Academy Of Dermatology Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/ALMS/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":9.905,"timestamp":1789070312006,"preClose":9.8,"halted":0,"volume":3869679,"delay":0,"changeRate":0.010714285714285576,"floatShares":104000000,"shares":129000000,"eps":-3.800544,"marketStatus":"Trading","change":0.105,"latestTime":"09-10 15:58:33 EDT","open":10.55,"high":10.55,"low":9.65,"amount":38485377.827193,"amplitude":0.091837,"askPrice":9.91,"askSize":1152,"bidPrice":9.9,"bidSize":4493,"shortable":3,"etf":0,"ttmEps":-3.800544,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":9.8,"preHourTrading":{"tag":"盘前","latestPrice":10.58,"preClose":9.8,"latestTime":"09:29 EDT","volume":48221,"amount":501737.74493349995,"timestamp":1789046986722,"change":0.78,"changeRate":0.079592,"amplitude":0.043439},"postHourTrading":{"tag":"盘后","latestPrice":9.82,"preClose":9.8,"latestTime":"19:43 EDT","volume":204775,"amount":2007264.3829,"timestamp":1788997404455,"change":0.02,"changeRate":0.002041,"amplitude":0.021429},"volumeRatio":0.660227,"impliedVol":0.8161,"impliedVolPercentile":0.1912},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":104000000,"roa":"-45.34%","roe":"-93.65%","lyrEps":-2.861649,"volumeRatio":0.660227,"shares":129000000,"dividePrice":0,"high":10.55,"amplitude":0.091837,"preClose":9.8,"low":9.65,"week52Low":3.76,"pbRate":"2.83","psRate":"172.71","week52High":31.35,"institutionHeld":0,"latestPrice":9.905,"committee":0.591851,"eps":-3.800544,"divideRate":0,"volume":3869679,"delay":0,"ttmEps":-3.800544,"open":10.55,"prevYearClose":9.76,"prevWeekClose":11.1,"prevMonthClose":21.81,"prevQuarterClose":28.14,"fiveDayClose":10.35,"twentyDayClose":25.55,"sixtyDayClose":23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ALMS","fiscalQuarterEnding":"2026/06","expectedEps":-0.7,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.78},{"market":"US","date":"2026-05-14","symbol":"ALMS","fiscalQuarterEnding":"2026/03","expectedEps":-0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2026-03-19","symbol":"ALMS","fiscalQuarterEnding":"2025/12","expectedEps":-0.97,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2025-11-13","symbol":"ALMS","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2025-08-13","symbol":"ALMS","fiscalQuarterEnding":"2025/06","expectedEps":-1.11,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.4,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1788408000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2026-09-09","current":-2.578578,"percent":0.504537,"low":-16.271116,"twenty":-12.268318,"median":-3.137731,"eighty":-1.170751,"high":-0.443678,"avg":-5.273621,"sd":5.017137,"marketCap":1369424828},"quantilePoints":[{"date":"2024-06-28","current":-4.084559,"twenty":-4.913756,"median":-4.913756,"eighty":-4.416238,"marketCap":689534895},{"date":"2024-07-05","current":-3.516406,"twenty":-4.747917,"median":-3.851156,"eighty":-3.59564,"marketCap":593622147},{"date":"2024-07-12","current":-3.405847,"twenty":-4.063676,"median":-3.825051,"eighty":-3.58397,"marketCap":574958044},{"date":"2024-07-19","current":-4.023985,"twenty":-4.026561,"median":-3.851156,"eighty":-3.52869,"marketCap":679309112},{"date":"2024-07-26","current":-4.023985,"twenty":-4.117224,"median":-3.947896,"eighty":-3.58397,"marketCap":679309112},{"date":"2024-08-02","current":-4.178507,"twenty":-4.123137,"median":-3.980142,"eighty":-3.620209,"marketCap":705394582},{"date":"2024-08-09","current":-3.850149,"twenty":-4.108328,"median":-3.938677,"eighty":-3.693301,"marketCap":649962958},{"date":"2024-08-16","current":-3.683794,"twenty":-4.085032,"median":-3.914533,"eighty":-3.659692,"marketCap":696362265},{"date":"2024-08-23","current":-3.672282,"twenty":-4.078883,"median":-3.855481,"eighty":-3.667968,"marketCap":694186133},{"date":"2024-08-30","current":-3.655014,"twenty":-4.050383,"median":-3.84693,"eighty":-3.659692,"marketCap":690921935},{"date":"2024-09-06","current":-3.442045,"twenty":-4.027205,"median":-3.798947,"eighty":-3.608967,"marketCap":650663491},{"date":"2024-09-13","current":-3.33556,"twenty":-4.023985,"median":-3.741353,"eighty":-3.511116,"marketCap":630534270},{"date":"2024-09-20","current":-3.301025,"twenty":-4.023985,"median":-3.709695,"eighty":-3.405847,"marketCap":624005873},{"date":"2024-09-27","current":-3.211808,"twenty":-3.980142,"median":-3.685233,"eighty":-3.395997,"marketCap":607140850},{"date":"2024-10-04","current":-2.803137,"twenty":-3.959602,"median":-3.672282,"eighty":-3.303903,"marketCap":529888161},{"date":"2024-10-11","current":-2.978693,"twenty":-3.946725,"median":-3.656453,"eighty":-3.263611,"marketCap":563074175},{"date":"2024-10-18","current":-3.462191,"twenty":-3.930629,"median":-3.608967,"eighty":-3.220442,"marketCap":654471723},{"date":"2024-10-25","current":-3.424777,"twenty":-3.915649,"median":-3.608753,"eighty":-3.22332,"marketCap":647399293},{"date":"2024-11-01","current":-3.254977,"twenty":-3.914533,"median":-3.516406,"eighty":-3.231953,"marketCap":615301345},{"date":"2024-11-08","current":-3.459313,"twenty":-3.86344,"median":-3.50536,"eighty":-3.240587,"marketCap":653927690},{"date":"2024-11-15","current":-2.016571,"twenty":-3.859807,"median":-3.465068,"eighty":-3.22332,"marketCap":481504843},{"date":"2024-11-22","current":-2.155567,"twenty":-3.851156,"median":-3.454996,"eighty":-3.18015,"marketCap":514693313},{"date":"2024-11-29","current":-2.109995,"twenty":-3.85035,"median":-3.444923,"eighty":-3.067334,"marketCap":503811848},{"date":"2024-12-06","current":-2.050751,"twenty":-3.847574,"median":-3.439167,"eighty":-2.978693,"marketCap":489665943},{"date":"2024-12-13","current":-1.911755,"twenty":-3.823752,"median":-3.419021,"eighty":-2.94646,"marketCap":456477473},{"date":"2024-12-20","current":-2.009736,"twenty":-3.802749,"median":-3.405847,"eighty":-2.329653,"marketCap":479872624},{"date":"2024-12-27","current":-1.836561,"twenty":-3.764391,"median":-3.395997,"eighty":-2.153744,"marketCap":438523055},{"date":"2025-01-03","current":-1.925427,"twenty":-3.741353,"median":-3.367218,"eighty":-2.142807,"marketCap":459741913},{"date":"2025-01-10","current":-1.595028,"twenty":-3.741353,"median":-3.312536,"eighty":-2.023407,"marketCap":380851289},{"date":"2025-01-17","current":-1.745417,"twenty":-3.740777,"median":-3.298147,"eighty":-1.989684,"marketCap":416760124},{"date":"2025-01-24","current":-1.522113,"twenty":-3.738475,"median":-3.27944,"eighty":-1.964163,"marketCap":363440944},{"date":"2025-01-31","current":-1.704402,"twenty":-3.735597,"median":-3.263611,"eighty":-1.93682,"marketCap":406966805},{"date":"2025-02-07","current":-1.291973,"twenty":-3.709695,"median":-3.247782,"eighty":-1.911755,"marketCap":308489544},{"date":"2025-02-14","current":-1.187157,"twenty":-3.703939,"median":-3.22332,"eighty":-1.873019,"marketCap":283462173},{"date":"2025-02-21","current":-1.178042,"twenty":-3.690125,"median":-3.211808,"eighty":-1.829725,"marketCap":281285880},{"date":"2025-02-28","current":-1.059555,"twenty":-3.68437,"median":-3.162882,"eighty":-1.759544,"marketCap":252994070},{"date":"2025-03-07","current":-1.111963,"twenty":-3.676887,"median":-3.070787,"eighty":-1.711693,"marketCap":265507755},{"date":"2025-03-14","current":-1.041326,"twenty":-3.672858,"median":-3.006033,"eighty":-1.678881,"marketCap":248641484},{"date":"2025-03-21","current":-0.693421,"twenty":-3.667968,"median":-2.978693,"eighty":-1.565406,"marketCap":204027476},{"date":"2025-03-28","current":-1.042906,"twenty":-3.659692,"median":-2.965742,"eighty":-1.505251,"marketCap":306857324},{"date":"2025-04-04","current":-1.85837,"twenty":-3.65559,"median":-2.803137,"eighty":-1.500694,"marketCap":546793636},{"date":"2025-04-11","current":-1.198232,"twenty":-3.63199,"median":-2.286587,"eighty":-1.463027,"marketCap":352559478},{"date":"2025-04-17","current":-0.924562,"twenty":-3.622781,"median":-2.176074,"eighty":-1.280365,"marketCap":272036635},{"date":"2025-04-25","current":-0.791425,"twenty":-3.613572,"median":-2.146452,"eighty":-1.183511,"marketCap":232863359},{"date":"2025-05-02","current":-0.848748,"twenty":-3.60871,"median":-2.125945,"eighty":-1.162092,"marketCap":249729630},{"date":"2025-05-09","current":-0.930109,"twenty":-3.590112,"median":-2.016571,"eighty":-1.140673,"marketCap":273668854},{"date":"2025-05-16","current":-0.890525,"twenty":-3.561975,"median":-1.997203,"eighty":-1.105127,"marketCap":305759157},{"date":"2025-05-23","current":-0.766929,"twenty":-3.530406,"median":-1.968721,"eighty":-1.070948,"marketCap":263322832},{"date":"2025-05-30","current":-0.619565,"twenty":-3.51429,"median":-1.964163,"eighty":-1.045883,"marketCap":212725677},{"date":"2025-06-06","current":-0.530829,"twenty":-3.506511,"median":-1.95277,"eighty":-1.037224,"marketCap":182258572},{"date":"2025-06-13","current":-0.503891,"twenty":-3.48667,"median":-1.925427,"eighty":-0.984896,"marketCap":173009629},{"date":"2025-06-20","current":-0.476954,"twenty":-3.466829,"median":-1.916313,"eighty":-0.943233,"marketCap":163760687},{"date":"2025-06-27","current":-0.522906,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"marketCap":179538295},{"date":"2025-07-03","current":-0.538752,"twenty":-3.462191,"median":-1.878715,"eighty":-0.88573,"marketCap":184978849},{"date":"2025-07-11","current":-0.564105,"twenty":-3.459313,"median":-1.85837,"eighty":-0.848748,"marketCap":193683736},{"date":"2025-07-18","current":-0.556182,"twenty":-3.450679,"median":-1.833144,"eighty":-0.808067,"marketCap":190963459},{"date":"2025-07-25","current":-0.611642,"twenty":-3.444923,"median":-1.819538,"eighty":-0.791425,"marketCap":210005399},{"date":"2025-08-01","current":-0.65601,"twenty":-3.444923,"median":-1.768203,"eighty":-0.766929,"marketCap":225238952},{"date":"2025-08-08","current":-1.301335,"twenty":-3.442045,"median":-1.745417,"eighty":-0.761839,"marketCap":446809517},{"date":"2025-08-15","current":-2.007939,"twenty":-3.439167,"median":-1.743138,"eighty":-0.765537,"marketCap":456842285},{"date":"2025-08-22","current":-2.103991,"twenty":-3.427655,"median":-1.761367,"eighty":-0.766929,"marketCap":478695789},{"date":"2025-08-29","current":-2.14973,"twenty":-3.424777,"median":-1.805264,"eighty":-0.766929,"marketCap":489102219},{"date":"2025-09-05","current":-2.103991,"twenty":-3.415567,"median":-1.826307,"eighty":-0.771366,"marketCap":478695789},{"date":"2025-09-12","current":-1.994217,"twenty":-3.40866,"median":-1.836561,"eighty":-0.773109,"marketCap":453720356},{"date":"2025-09-19","current":-1.9622,"twenty":-3.406179,"median":-1.867544,"eighty":-0.787793,"marketCap":446435855},{"date":"2025-09-26","current":-1.824983,"twenty":-3.405847,"median":-1.875296,"eighty":-0.795863,"marketCap":415216564},{"date":"2025-10-03","current":-1.811262,"twenty":-3.397967,"median":-1.860219,"eighty":-0.799931,"marketCap":412094635},{"date":"2025-10-10","current":-2.071974,"twenty":-3.391392,"median":-1.873019,"eighty":-0.803629,"marketCap":471411288},{"date":"2025-10-17","current":-2.108565,"twenty":-3.371823,"median":-1.884428,"eighty":-0.807327,"marketCap":479736432},{"date":"2025-10-24","current":-2.108565,"twenty":-3.341892,"median":-1.893592,"eighty":-0.812505,"marketCap":479736432},{"date":"2025-10-31","current":-2.131434,"twenty":-3.317141,"median":-1.904969,"eighty":-0.82249,"marketCap":484939647},{"date":"2025-11-07","current":-2.158878,"twenty":-3.30563,"median":-1.911755,"eighty":-0.843135,"marketCap":491183505},{"date":"2025-11-14","current":-2.422653,"twenty":-3.301601,"median":-1.918592,"eighty":-0.848547,"marketCap":551197167},{"date":"2025-11-21","current":-2.946741,"twenty":-3.29642,"median":-1.93682,"eighty":-0.86502,"marketCap":722402348},{"date":"2025-11-28","current":-3.266113,"twenty":-3.290089,"median":-1.953052,"eighty":-0.869088,"marketCap":800697401},{"date":"2025-12-05","current":-3.534386,"twenty":-3.297571,"median":-1.962042,"eighty":-0.870197,"marketCap":866465244},{"date":"2025-12-12","current":-4.943882,"twenty":-3.336738,"median":-1.966442,"eighty":-0.879813,"marketCap":1212007408},{"date":"2025-12-19","current":-4.709675,"twenty":-3.399937,"median":-1.972322,"eighty":-0.888607,"marketCap":1154591037},{"date":"2025-12-26","current":-4.854457,"twenty":-3.410963,"median":-1.990368,"eighty":-0.898223,"marketCap":1190084794},{"date":"2026-01-02","current":-4.156097,"twenty":-3.436865,"median":-1.996504,"eighty":-0.911618,"marketCap":1018879613},{"date":"2026-01-09","current":-7.741582,"twenty":-3.449528,"median":-2.003365,"eighty":-0.920124,"marketCap":1897872066},{"date":"2026-01-16","current":-12.290084,"twenty":-3.466829,"median":-2.013154,"eighty":-0.925671,"marketCap":3012950964},{"date":"2026-01-23","current":-13.362987,"twenty":-3.516406,"median":-2.019374,"eighty":-0.930109,"marketCap":3275976472},{"date":"2026-01-30","current":-13.647739,"twenty":-3.577828,"median":-2.030809,"eighty":-0.937506,"marketCap":3345784190},{"date":"2026-02-06","current":-13.393497,"twenty":-3.626234,"median":-2.053678,"eighty":-0.942816,"marketCap":3283455871},{"date":"2026-02-13","current":-13.6274,"twenty":-3.672282,"median":-2.062826,"eighty":-0.944902,"marketCap":3340797925},{"date":"2026-02-20","current":-14.850306,"twenty":-3.690125,"median":-2.071974,"eighty":-0.965612,"marketCap":3640597141},{"date":"2026-02-27","current":-15.244382,"twenty":-3.739051,"median":-2.087982,"eighty":-0.981145,"marketCap":3737206037},{"date":"2026-03-06","current":-14.054527,"twenty":-3.801818,"median":-2.103991,"eighty":-0.986058,"marketCap":3445509501},{"date":"2026-03-13","current":-12.727381,"twenty":-3.85035,"median":-2.108565,"eighty":-0.99467,"marketCap":3120155674},{"date":"2026-03-20","current":-13.002303,"twenty":-3.914756,"median":-2.117713,"eighty":-1.01599,"marketCap":3163785497},{"date":"2026-03-27","current":-13.758909,"twenty":-3.96371,"median":-2.12686,"eighty":-1.031756,"marketCap":3347886444},{"date":"2026-04-02","current":-11.882219,"twenty":-4.025273,"median":-2.141239,"eighty":-1.038592,"marketCap":2891240839},{"date":"2026-04-10","current":-11.991997,"twenty":-4.096739,"median":-2.146452,"eighty":-1.041326,"marketCap":2917952699},{"date":"2026-04-17","current":-13.068872,"twenty":-4.165061,"median":-2.15037,"eighty":-1.042274,"marketCap":3179983325},{"date":"2026-04-24","current":-13.5864,"twenty":-4.472062,"median":-2.155567,"eighty":-1.044692,"marketCap":3305910664},{"date":"2026-05-01","current":-12.906818,"twenty":-4.742038,"median":-2.161164,"eighty":-1.045883,"marketCap":3140551531},{"date":"2026-05-08","current":-12.420656,"twenty":-4.831463,"median":-2.172599,"eighty":-1.054086,"marketCap":3022256152},{"date":"2026-05-15","current":-13.226323,"twenty":-4.877452,"median":-2.191451,"eighty":-1.062289,"marketCap":3140127467},{"date":"2026-05-22","current":-11.905302,"twenty":-5.029048,"median":-2.200043,"eighty":-1.070948,"marketCap":2826497196},{"date":"2026-05-29","current":-11.491811,"twenty":-7.697296,"median":-2.214811,"eighty":-1.081885,"marketCap":2728328372},{"date":"2026-06-05","current":-10.949441,"twenty":-10.746475,"median":-2.229773,"eighty":-1.094189,"marketCap":2599561472},{"date":"2026-06-12","current":-11.223311,"twenty":-10.767935,"median":-2.309816,"eighty":-1.101025,"marketCap":2664582382},{"date":"2026-06-18","current":-12.377862,"twenty":-10.942997,"median":-2.358363,"eighty":-1.105127,"marketCap":2938690139},{"date":"2026-06-26","current":-13.441123,"twenty":-11.434889,"median":-2.409687,"eighty":-1.106494,"marketCap":3191124259},{"date":"2026-07-02","current":-14.305694,"twenty":-11.51629,"median":-2.443671,"eighty":-1.111963,"marketCap":3396386347},{"date":"2026-07-10","current":-16.271116,"twenty":-11.77244,"median":-2.7977,"eighty":-1.135362,"marketCap":3863006994},{"date":"2026-07-17","current":-14.622524,"twenty":-11.882219,"median":-2.91667,"eighty":-1.139306,"marketCap":3471606615},{"date":"2026-07-24","current":-15.197115,"twenty":-11.985852,"median":-2.970059,"eighty":-1.141585,"marketCap":3608023034},{"date":"2026-07-31","current":-15.546165,"twenty":-12.051591,"median":-2.978693,"eighty":-1.145231,"marketCap":3690892821},{"date":"2026-08-07","current":-14.928615,"twenty":-12.229666,"median":-3.006033,"eighty":-1.151611,"marketCap":3544277044},{"date":"2026-08-14","current":-13.30798,"twenty":-12.354486,"median":-3.070787,"eighty":-1.160269,"marketCap":3159514183},{"date":"2026-08-21","current":-6.740728,"twenty":-12.30227,"median":-3.108556,"eighty":-1.162092,"marketCap":2958889563},{"date":"2026-08-28","current":-6.843932,"twenty":-12.28999,"median":-3.129848,"eighty":-1.162092,"marketCap":3004191897},{"date":"2026-09-04","current":-3.349723,"twenty":-12.282955,"median":-3.137731,"eighty":-1.167561,"marketCap":1470384315},{"date":"2026-09-09","current":-3.119724,"twenty":-12.268318,"median":-3.137731,"eighty":-1.170751,"marketCap":1369424828}],"updateTime":1789037291280},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620623271","title":"Alumis Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620623271","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620623271?lang=en_us&edition=fundamental","pubTime":"2026-03-20 05:03","pubTimestamp":1773954219,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nFWN4071BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620227181","title":"Alumis Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2620227181","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620227181?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:54","pubTimestamp":1773953652,"startTime":"0","endTime":"0","summary":"Alumis Inc reports results for the quarter ended December 31 - Earnings SummaryAlumis Inc ALMS.OQ reported a quarterly adjusted loss of 94 cents per share for the quarter ended December 31, lower than","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nL8N4072VM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620279596","title":"Alumis Q4 Sales $1.929M Miss $2.833M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2620279596","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620279596?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:26","pubTimestamp":1773951966,"startTime":"0","endTime":"0","summary":"Alumis (NASDAQ:ALMS) reported quarterly sales of $1.929 million which missed the analyst consensus estimate of $2.833 million by 31.92 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51368744/alumis-q4-sales-1-929m-miss-2-833m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alumis Q4 Sales $1.929M Miss $2.833M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620279819","title":"Alumis Inc. publishes corporate presentation on precision-engineered TYK2 inhibitors for immune-mediated diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2620279819","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620279819?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:19","pubTimestamp":1773951599,"startTime":"0","endTime":"0","summary":"Alumis highlighted Phase 3 topline data for envudeucitinib in moderate-to-severe plaque psoriasis from the ONWARD1 and ONWARD2 trials, which used placebo and apremilast comparators over 24 weeks.At Week 16, envudeucitinib 40 mg BID showed PASI 75 of 74% and sPGA 0/1 of 59%.By Week 24, PASI 90 was 65% and PASI 100 was above 40%.The company said more than 1,700 patients were enrolled across more than 270 study sites in 10 months.Alumis listed anticipated milestones including an NDA filing for psoriasis and Phase 2b SLE topline data expected in Q3 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief on March 19, 2026, and is solely responsible for the information ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL4WctQz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620276440","title":"Alumis FY 2025 G&A expenses jumped 161% to USD 91.86 million as net loss narrowed 17% to USD 243.33 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620276440","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620276440?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:07","pubTimestamp":1773950863,"startTime":"0","endTime":"0","summary":"Alumis published a year-end 2025 financial results press release, reporting total revenue of USD 24.05 million and a net loss of USD 243.33 million.Research and development expenses rose 45.36% to USD 386 million, driven by contract research and clinical trial costs for envudeucitinib and other programs, plus higher headcount and merger-related severance costs.General and administrative expenses increased more than doubled to USD 91.86 million, reflecting transaction and severance costs tied to the ACELYRIN merger and higher headcount and professional consulting services.Cash, cash equivalents and marketable securities totaled USD 308.5 million at year-end, and the company said it expects this plus USD 324.4 million in net proceeds from a January 2026 stock offering to fund operations into Q4 2027.Management said Phase 3 ONWARD1 and ONWARD2 trials of envudeucitinib in plaque psoriasis met all primary and secondary endpoints, and reiterated plans for an NDA submission in psoriasis in 2H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL6Htsj8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","ALMS","NDAQ","BK4007","IE00BGHQF748.EUR","LU2210150020.SGD","BK4112","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","IE00B64PRP62.GBP","IE00BN0W2W23.USD","LU0314104364.USD","BK4588","SG9999014013.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620276193","title":"Press Release: Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements","url":"https://stock-news.laohu8.com/highlight/detail?id=2620276193","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620276193?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:05","pubTimestamp":1773950700,"startTime":"0","endTime":"0","summary":"-- Positive Phase 3 topline results demonstrating envudeucitinib's leading skin clearance, meaningful symptom improvement and a favorable safety profile in patients with moderate-to-severe plaque psoriasis  --. -- Plan to submit NDA for envudeucitinib in PsO in 2H 2026 --. -- Potentially pivotal Phase 2b clinical topline data for envudeucitinib in systemic lupus erythematosus  anticipated 3Q 2026 --. \"Alumis concluded a pivotal year marked by strong execution and the Phase 3 clinical validation of envudeucitinib in moderate-to-severe plaque psoriasis, underscoring the promise of TYK2 inhibition and envudeucitinib's highly differentiated clinical profile,\" said Martin Babler, President and Chief Executive Officer of Alumis. \"By maximally inhibiting TYK2 to block both IL-23 and IL-17 pathways, envudeucitinib delivered comprehensive disease control with rapid onset of action, high rates of skin clearance, and meaningful symptom improvements in our Phase 3 ONWARD program that reinforce our","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4007","SLE","BK4077","KOL","BK4135","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620253326","title":"Alumis sets late-breaking AAD 2026 oral presentation of Phase 3 ONWARD1 and ONWARD2 envudeucitinib psoriasis data","url":"https://stock-news.laohu8.com/highlight/detail?id=2620253326","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620253326?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:04","pubTimestamp":1773835487,"startTime":"0","endTime":"0","summary":"Alumis said 24-week results from the Phase 3 ONWARD1 and ONWARD2 trials of envudeucitinib , an oral TYK2 inhibitor for moderate-to-severe plaque psoriasis, will be presented as a late-breaking oral session at the 2026 American Academy of Dermatology Annual Meeting in Denver. The oral presentation is scheduled for March 28, 2026, at 11:12 am MDT at Bellco Theatre 3. Alumis also said a subgroup analysis from the Phase 2 STRIDE trial on proteomic and transcriptomic tape-strip biomarkers will be presented as an e-poster  at the same meeting. The company plans to post the presentations on its website on March 28, 2026, in line with the meeting’s embargo policy. Alumis also scheduled an investor webcast on March 29, 2026, at 5:00 pm MDT to review the Phase 3 ONWARD data.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLftG8V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","ALMS","NDAQ","BK4007","IE00BGHQF748.EUR","LU2210150020.SGD","BK4112","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","IE00B64PRP62.GBP","IE00BN0W2W23.USD","LU0314104364.USD","BK4588","SG9999014013.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620873253","title":"BRIEF-Alumis Announces Late-Breaker Oral Presentation Of Phase 3 Data For Envudeucitinib In Moderate-To-Severe Plaque Psoriasis At 2026 American Academy Of Dermatology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2620873253","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620873253?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:02","pubTimestamp":1773835350,"startTime":"0","endTime":"0","summary":"BRIEF-Alumis Announces Late-Breaker Oral Presentation Of Phase 3 Data For Envudeucitinib In Moderate-To-Severe Plaque Psoriasis At 2026 American Academy Of Dermatology Annual MeetingMarch 18 (Reuters)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nTUA9PTTYV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":7,"totalSize":128,"code":"91000000","status":"200"}]}}